Kratos (KTOS) Q2 2026 Earnings Call Transcript

Kratos reported Q2 2026 revenue of $458.8M (+30.5% YoY; 19.1% organic) and adjusted EPS of $0.21 (up from $0.11), with adjusted EBITDA of $38.2M beating an estimated $30M–$35M range. The company ended Q2 with $2.084B backlog (including $1.572B funded) and a $15B bid/proposal pipeline, and raised full-year 2026 revenue guidance to $1.750B–$1.810B (organic growth now 18%–23%). Hypersonics growth expectations were reiterated (about $400M in 2026, at least $700M in 2027) alongside an EBITDA margin improvement target of +100 bps vs. 2025, despite $5M–$7M estimated EBITDA headwinds from Israeli shekel strength.

Analysis

The market should treat this less as a one-quarter beat and more as a proof point that Kratos is becoming a picks-and-shovels supplier to the Pentagon’s shift toward cheap, high-volume munitions and autonomous systems. The second-order beneficiary is GE Aerospace: Kratos is effectively de-risking future turbofan demand by putting capacity and supply-chain commitments in place ahead of volume, which lowers the probability that GE’s small-engine franchise remains a niche. By contrast, large primes exposed to exquisite platforms may see relative mix pressure if budget share keeps migrating to attritable systems, even if total defense spend rises.

The real issue is not demand; it is execution timing and cash conversion. This is a classic “capex now, revenue later” setup where working capital, inventory builds, and prepayments will likely suppress free cash flow for several quarters, so headline growth can outrun economic earnings. The near-term catalyst path is still favorable into the next 1-2 quarters because the company has multiple program starts and production ramps that should keep the revenue comp strong, but the stock can be vulnerable if investors demand proof that billings and EBITDA are compounding faster than invested capital.

Contrarian view: consensus may be underestimating how much of the growth is already implicitly discounted by the market’s enthusiasm for defense/autonomy. The more important risk is not a weak demand environment but a slip in certification, supplier qualification, or customer timing on the new engine and drone lines; any such delay would push out the 2027-2028 step-up and compress the multiple quickly. The thesis is falsified if operating cash burn persists after the current build phase without a visible inflection in milestone billings and gross margin leverage over the next 2-3 quarters.

Key Decisions for Investors

• Long KTOS on any post-earnings consolidation, targeting a 3-6 month hold into the next two quarters of production-ramp updates; thesis is that guidance credibility plus visible 2027 capacity should support multiple expansion if cash burn does not worsen materially.
• Pair trade: long KTOS / short ITA or XAR for the next 3-6 months. The bet is that the market will re-rate the fastest-growing low-cost mass exposure above the broader defense basket if program execution stays on schedule.
• Watch list, not a trade yet: GE on pullbacks. Kratos’ engine roadmap makes GE a quiet levered beneficiary, but the equity impact is likely slower and less asymmetric than KTOS unless the Oklahoma turbofan program shows earlier-than-expected volume pull-through.
• Avoid chasing KTOS after gap-ups until the next filing/call confirms that receivables and inventory are normalizing. Falsifier for the bullish setup is another quarter of heavy FCF drag without a corresponding improvement in billings or gross margin.
• For higher-risk accounts, consider a limited-risk KTOS call spread expiring after the next two catalysts if the stock retraces. Use it only if you want convexity to a 2027 ramp thesis; otherwise shares are cleaner given execution risk.